Pascal Delsart

ORCID: 0000-0003-3091-6119
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Aortic aneurysm repair treatments
  • Renal and Vascular Pathologies
  • Aortic Disease and Treatment Approaches
  • Healthcare Systems and Practices
  • Cardiovascular Health and Disease Prevention
  • Cardiac Valve Diseases and Treatments
  • Cardiovascular Function and Risk Factors
  • Cardiac, Anesthesia and Surgical Outcomes
  • Obstructive Sleep Apnea Research
  • Peripheral Artery Disease Management
  • Heart Rate Variability and Autonomic Control
  • Acute Myocardial Infarction Research
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiovascular and Diving-Related Complications
  • Hemodynamic Monitoring and Therapy
  • Cardiovascular Issues in Pregnancy
  • Pregnancy and preeclampsia studies
  • Acute Ischemic Stroke Management
  • Hormonal Regulation and Hypertension
  • Cardiovascular Disease and Adiposity
  • Cardiovascular and exercise physiology
  • Heart Failure Treatment and Management
  • Sodium Intake and Health
  • Health, Medicine and Society

Institut Pasteur de Lille
2018-2023

Centre Hospitalier Universitaire de Lille
2014-2023

Société Française de Médecine Vasculaire
2009-2023

Université de Lille
2009-2023

Inserm
2011-2023

Radiance Technologies (United States)
2022-2023

Université Sorbonne Paris Nord
2016-2021

IMPact de l'Environnement Chimique sur la Santé humaine
2019

Lille’s Cardiology Hospital
2009-2018

Hôpital Européen Georges-Pompidou
2016-2017

Markus P. Schlaich M Bellet Michael A. Weber Parisa Danaietash George L. Bakris and 95 more John M. Flack Roland F. Dreier Mouna Sassi-Sayadi Lloyd Haskell Krzysztof Narkiewicz Ji‐Guang Wang Christopher M. Reid Markus P. Schlaich Ivor Katz Andrew E. Ajani Sinjini Biswas Murray Esler Grahame J. Elder Simon D. Roger David Colquhoun John G. Mooney Tine De Backer Alexandre Persu Martin Chaumont Jean-Marie Krzesinski Thomas Vanassche Ginette Girard Lew Pliamm Ernesto L. Schiffrin Fatima Merali George K. Dresser Michel Vallée Shivinder Jolly S. P. Chow Ji‐Guang Wang Jianjun Mu Jing Yu Hong Yuan Yingqing Feng Xin Zhang Jianhong Xie Ling Lin Miroslav Souček J Widimský Renata Cífková J. Václavík Martin Ullrych Martin Lukáč Ivan Rychlík Thomas Guldager Lauridsen Ilkka Kantola Jyrki Taurio Olavi Ukkola Olivier Ormezzano Philippe Gosse Michel Azizi Pierre‐Yves Courand Pascal Delsart Jean Michel Tartiere Felix Mahfoud Roland E. Schmieder Johannes Stegbauer Philipp Lurz Michael Koziolek Christian Ott Nicole Toursarkissian Konstantinos Tsioufis K. Kyfnidis Athanasios Manolis Sotirios Patsilinakos Pantelis Zebekakis Apostolos Karavidas Pall Denes Katalin Bezzegh Marianna Zsom László Kovács Yehonatan Sharabi Mazen Elias Ivetta Sukholutsky Chaim Yosefy Irina Kenis Shaul Atar Massimo Volpe Muiesan Maria Lorenza Stefano Taddei Guıdo Grassı Franco Veglio Jung‐Woo Son Jang‐Young Kim Joong-Il Park Chang Hoon Lee Hae‐Young Lee Rasa Raugalienė Jolanta Elena Marcinkeviciene Roma Kavaliauskiene Jaap Deinum Abraham A. Kroon Bert‐Jan H. van den Born Andrzej Januszewicz Andrzej Tykarski

10.1016/s0140-6736(22)02034-7 article EN The Lancet 2022-11-07

Background: The DENERHTN trial (Renal Denervation for Hypertension) confirmed the blood pressure–lowering efficacy of renal denervation added to a standardized stepped-care antihypertensive treatment resistant hypertension at 6 months. We report influence adherence on pressure control. Methods: One hundred six patients with 4 weeks indapamide 1.5 mg/d, ramipril 10 mg/d (or irbesartan 300 mg/d), and amlodipine were randomly assigned plus treatment, or same alone. For spironolactone 25...

10.1161/circulationaha.116.022922 article EN Circulation 2016-08-31

Functional renal impairment is a common feature of heart failure with preserved ejection fraction (HFpEF). The link between functional and HFpEF remains incompletely understood. With hypertension diabetes as frequent co-morbidities, patients are at risk developing intra-renal vascular hemodynamic alterations that may lead to impact on prognosis.Renal resistive index (RRI) was non-invasively determined by Doppler ultrasonic examination in 90 age- sex-matched hypertensive without evidence (HF)...

10.1093/ndt/gfr116 article EN Nephrology Dialysis Transplantation 2011-03-18
Augustin Coisne David Montaigne Samy Aghezzaf Hélène Ridon S. Mouton and 95 more Marjorie Richardson Anne‐Sophie Polge Patrizio Lancellotti Christophe Bauters Luc Abramovici Jean-Charles Aisenfarb Moulay Alaoui Ahmed Amiar Mariam Arabidze Valérie Aumégeat Laurence Avez-Lemaire Hélène Bardet Karine Bauley J Becquart Aida Ben Abda Frédéric Biausque Fanny Boudghene Stambouli Bertrand Boutié D. Broucqsault Jean-Michel Bruffau B Brullard Laurent Carpentier Sébastien Caudmont Karim Chachoua Akram Chmaït Maïwenn Clement-Dupont Christophe Cordier Alessandro Cosenza J Coulomb Vladimir Cousin Elise Dassonvalle Guillaume de Geeter Pascal de Groote Eric Decoulx M Delomez Pascal Delsart François Destombes Nicolas Détis Michel Devillers Olivia Domanski Audrey Duchemin Xavier Dujardin Anju Duva Pentiah Nima Endjah O Equine Marie Fertin Bruno Fournier Dauphine Garin Antonio Gongora Lorraine Greffe G. Hannebicque Jérôme Haye Eléonore Hebbar Vincent Hennebelle Olivier Hennebert Gérard Houdain Arnaud Hubert C Hudelo Thibault Hus Olivier Jabourek Mathilde Jacquelinet T Jacquemart Belaid Jellouli Antoine Jeu Messaoud Kouidri Francis Kozlowski Robert Lallemant Nicolas Lamblin Patricia Langlois Guillaume Ledieu Yann Lefetz Philippe Lejeune François Leleu Nestor Lemaire Rémy Lubret Anne‐Laure Madika Philippe Marboeuf Thibaud Meurice Jonathan Meurice A Millaire Frédéric Mouquet Aurélie Musschoot Christophe Mycinski Dan Valentin Neicu Olivier Nugue Rahma Ouardani Karima Ouchallal François Passard Max Pécheux Karine Pedelhez Alain Petit André Philias Rosario Pilato P Pruvost Arnaud Quercy

<h3>Importance</h3> Modern data regarding incidence and modes of death patients with aortic stenosis (AS) are restricted to tertiary centers or studies valve replacement (AVR). <h3>Objective</h3> To provide new insights into the natural history outpatients native AS based on a large regionwide population study inclusion by all cardiologists regardless their mode practice. <h3>Design, Setting, Participants</h3> Between May 2016 December 2017, consecutive mild (peak velocity, 2.5-2.9 m/s),...

10.1001/jamacardio.2021.3718 article EN JAMA Cardiology 2021-09-29

The DENERHTN trial (Renal Denervation for Hypertension) confirmed the blood pressure (BP) lowering efficacy of renal denervation added to a standardized stepped-care antihypertensive treatment resistant hypertension at 6 months. We report here effect on 24-hour BP and its variability look parameters that predicted response. Patients with were randomly assigned plus or alone (control). Average standard deviation 24-hour, daytime, nighttime smoothness index calculated recordings performed...

10.1161/hypertensionaha.116.08448 article EN Hypertension 2017-01-24

We conducted a pilot multicenter double-blind randomized placebo-controlled crossover pharmacodynamic study to evaluate the blood pressure (BP) and hormonal effects of firibastat, first-in-class aminopeptidase A inhibitor prodrug, in patients with hypertension. Thirty-four daytime ambulatory BP at least 135/85 mmHg less than 170/105 mmHg, after 2-week run-in period were randomly assigned receive either firibastat (250 mg b.i.d. for 1 week uptitrated 500 3 weeks) then placebo 4 weeks each or...

10.1097/hjh.0000000000002092 article EN Journal of Hypertension 2019-03-19

PurposeTo evaluate contrast-enhanced ultrasound (CEUS) as an effective alternative to computed tomographic angiography (CTA) during follow-up after fenestrated endovascular aneurysm repair (EVAR) of juxtarenal aortic aneurysms. MethodsBetween January 2008 and April 2011, 62 patients (all men; mean age 72 years) underwent EVAR with both CTA CEUS. In a retrospective analysis, the first CEUS postoperative examinations were compared for endoleak detection, sac diameter, target vessel patency....

10.1583/jevt-12-3909r.1 article EN Journal of Endovascular Therapy 2012-10-01
Pierre‐Yves Courand Héléna Pereira Costantino Del Giudice Philippe Gosse Matthieu Monge and 95 more Guillaume Bobrie Pascal Delsart Claire Mounier‐Véhier Pierre Lantelme Thierry Denolle Caroline Dourmap Jean‐Michel Halimi Xavier Girerd Patrick Rossignol Faı̈ez Zannad Olivier Ormezzano B. Vaı̈sse D Herpin Jean Ribstein Béatrice Bouhanick Jean‐Jacques Mourad Émile Ferrari Gilles Châtellier Marc Sapoval Arshid Azarine Michel Azizi Laurence Amar G. Bobrie Aurélien Lorthioir Aurélien Lorthioir Matthieu Monge J Y Pagny J Y Pagny P.-F. Plouin P.-F. Plouin Marc Sapoval G. Claisse Pascal Delsart Marco Midulla Marco Midulla Claire Mounier‐Véhier Pierre‐Yves Courand Raphaël Dauphin Raphaël Dauphin J. P. Fauvel J. P. Fauvel Pierre Lantelme Olivier Rouvière Olivier Rouvière Antoine Crémer Philippe Gosse N. Grenier N. Grenier Y. Lebras Y. Lebras H. Trillaud H. Trillaud Thierry Denolle Caroline Dourmap-Collas Caroline Dourmap-Collas J.F. Heautot J.F. Heautot A. Larralde A. Larralde François Paillard François Paillard Philippe Cluzel Xavier Girerd David Rosenbaum D. Alison Jean‐Michel Halimi M. Claudon Batric Popovic Patrick Rossignol Faı̈ez Zannad J.-P. Baguet Olivier Ormezzano Frédéric Thony J.M. Bartoli B. Vaı̈sse J Drouineau D Herpin P. Sosner J.P. Tasu Sonia Velasco Jean Ribstein H. Kovacsik Béatrice Bouhanick B Chamontin H. Rousseau Sylvain Le Jeune Marilucy Lopez‐Sublet Jean‐Jacques Mourad L. Bellmann Vincent Esnault Émile Ferrari Marc Sapoval G. Bobrie Gilles Châtellier P.-F. Plouin

Background The DENERHTN (Renal Denervation for Hypertension) trial confirmed the efficacy of renal denervation (RDN) in lowering daytime ambulatory systolic blood pressure when added to standardized stepped‐care antihypertensive treatment (SSAHT) resistant hypertension at 6 months. Methods and Results This post hoc exploratory analysis assessed impact abdominal aortic calcifications (AAC) on hemodynamic response RDN In total, 106 patients with were randomly assigned plus SSAHT or same alone...

10.1161/jaha.117.007062 article EN cc-by-nc-nd Journal of the American Heart Association 2017-10-11

To compare the clinical significance of exercise echocardiography (ExE) and cardiopulmonary testing (CPX) in patients with ≥moderate primary mitral regurgitation (MR) discrepancy between symptoms MR severity.Patients consulting for discordant prospectively underwent low (25 W) ExE, peak CPX within 2 months Lille Rennes University Hospital. Patients Class I recommendation surgical correction were excluded. Changes severity, systolic pulmonary artery pressure (SPAP), left ventricular ejection...

10.1093/ehjci/jeab231 article EN European Heart Journal - Cardiovascular Imaging 2021-10-20

Although recommendations encourage daily moderate activities in post aortic dissection, very little data exists regarding cardiopulmonary exercise testing (CPET) to personalize those patient's physical rehabilitation and assess their cardiovascular prognosis.We aimed at the prognostic insight of CPET events by exploring a prospective cohort patients followed-up after acute dissection.Patients referred our department an (type A or B) dissection were prospectively included between September...

10.1002/clc.23537 article EN cc-by Clinical Cardiology 2020-12-31

The renal resistive index has been demonstrated to predict the progression of disease and recurrence major cardiac events in high-risk cardiovascular patients, addition other comorbidities. We aimed assess prognostic significance type 2 diabetic patients for primary prevention. From 2008 2011, with diabetes underwent evaluation, including assessment by Doppler ultrasound. incidence all-cause death, events, dialysis requirement or a twofold increase creatinine was recorded. Survival curves...

10.1111/jch.13819 article EN Journal of Clinical Hypertension 2020-01-31

Abstract Whether arterial stiffness is a surrogate end-point for cardiovascular and renal disease has never been directly demonstrated by controlled clinical trial. Our main hypothesis better prevention of outcomes in high risk hypertensives with PWV normalization driven strategy than usual blood pressure therapeutic based on European Society Hypertension—European Cardiology (ESH—ESC) guidelines. The preventing events study multicenter open-label randomized trial blinded endpoint evaluation...

10.2991/artres.k.200711.001 article EN cc-by Artery Research 2020-07-17

Objective Current data regarding the impact of diabetes mellitus (DM) on cardiovascular mortality in patients with aortic stenosis (AS) are restricted to severe AS or valve replacement (AVR) trials. We aimed investigate according DM across entire spectrum outpatients AS. Methods Between May 2016 and December 2017, mild (peak velocity=2.5–2.9 m/s), moderate (3–3.9 m/s) (≥4 graded by echocardiography were included during outpatient cardiology visits Nord-Pas-de-Calais region France followed-up...

10.1136/heartjnl-2022-320897 article EN Heart 2022-06-13

Abstract Aims To investigate the additional prognostic value of myocardial work (MW) parameters following acute infarction (AMI). Methods and results Between 2018 2020, 244 patients admitted in cardiac intensive care unit Lille University Hospital for AMI were included. One-month AMI, comprehensive transthoracic echocardiography (TTE) was performed to assess function. Patients then followed major events (ME): cardiovascular death, heart failure, unplanned coronary revascularization. At...

10.1093/ehjopen/oeac037 article EN cc-by-nc European Heart Journal Open 2022-05-01

The chronic management of post-acute aortic dissection (AD) the descending aorta (Type B) is based on optimal control blood pressure (BP), with a target BP < 135/80 mmHg. aim our study was to determine and verify effective an objective measurement method identify predicting factors.We collected data from 26 patients hospitalized in acute phase Type B AD between 2006 2009. Two groups were defined according 24 hour monitoring results at follow-up. Group 1 consisted controlled (<130/80 mmHg), 2...

10.2147/vhrm.s24473 article EN cc-by-nc Vascular Health and Risk Management 2012-01-01
Coming Soon ...